Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV cps2, Lot RSV#005A, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age
Brief Summary: Human respiratory syncytial virus (RSV) is a common cause of respiratory illness in infants and children. This study will evaluate the safety and immune response to an RSV vaccine in healthy RSV-naïve children.


Options:
A: Arm Label: Group 1: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 1: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Group 2: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 2: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Group 3: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 3: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Group 4: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 4: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: RSV ΔNS2 Δ1313 I1314L Vaccine; Assigned to Arm(s): Group 1: RSV vaccine, Group 2: RSV vaccine, Group 3: RSV vaccine, Group 4: RSV vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Group 1: Placebo, Group 2: Placebo, Group 3: Placebo, Group 4: Placebo
B: Arm Label: GSK3003891A vaccine formulation 1 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 1 | Arm Label: GSK3003891A vaccine formulation 2 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 2 | Arm Label: GSK3003891A vaccine formulation 3 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 3 | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (Formulation buffer S9b) | Intervention Type: BIOLOGICAL; Name: RSV Vaccine (GSK3003891A) formulation 1; Assigned to Arm(s): GSK3003891A vaccine formulation 1 Group | Intervention Type: BIOLOGICAL; Name: RSV Vaccine (GSK3003891A) formulation 2; Assigned to Arm(s): GSK3003891A vaccine formulation 2 Group | Intervention Type: BIOLOGICAL; Name: RSV Vaccine (GSK3003891A) formulation 3; Assigned to Arm(s): GSK3003891A vaccine formulation 3 Group | Intervention Type: DRUG; Name: Placebo (Formulation buffer S9b); Assigned to Arm(s): Control Group
C: Arm Label: Vaccine arm; Type: ACTIVE_COMPARATOR; Interventions: Biological: ShanChol | Arm Label: Vaccine plus hygiene and safe water arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Vaccine and behaviour | Arm Label: Non-intervention arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: ShanChol; Assigned to Arm(s): Vaccine arm | Intervention Type: BEHAVIORAL; Name: Vaccine and behaviour; Assigned to Arm(s): Vaccine plus hygiene and safe water arm
D: Arm Label: RSV cps2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV cps2 Vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo Vaccine | Intervention Type: BIOLOGICAL; Name: RSV cps2 Vaccine; Assigned to Arm(s): RSV cps2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo Vaccine; Assigned to Arm(s): Placebo

Answer: D